Tag Archives: Science

Prostate Cancer Drug so Effective Trial Stopped to Give Drug to All Participants

Prostate cancer drug so effective trial stopped by Victoria Colliver

The hormone treatment, Johnson & Johnson’s Zytiga, when added to a standard steroid therapy doubled the time it takes for the disease to progress in patients treated with the standard therapy alone, said the lead researcher, Dr. Charles Ryan, associate professor of clinical medicine at the UCSF Helen Diller Family Comprehensive Cancer Center.

The U.S. Food and Drug Administration last year approved Zytiga, also known as abiraterone, for use in men whose prostate cancer had spread to other parts of their body and had already been treated with chemotherapy.

This trial focused on patients whose cancer had metastasized, may have been treated with other hormone therapies but had not yet gone through chemotherapy.

Prostate cancer, the second most common form of cancer in males after only lung cancer, is diagnosed in about 200,000 men in the United States each year. And while it is generally treatable, the disease kills nearly 30,000 men a year.

Because their disease is often slow-growing, about a third of patients diagnosed with prostate cancer won’t be treated. Another third will undergo successful treatment, which could include surgery, various hormone therapies or chemotherapy.

Still, a third of patients will have recurrent or aggressive disease that may have been caught too late. Ryan said men tend to die when the cancer spreads outside the prostate, mostly to bone, and the patient becomes resistant to hormonal therapy. The cancer cells rely on testosterone to exist, so typically doctors treat patients with testosterone-blocking hormone therapy.

But patients become resistant when the cancer cells develop the ability to make their own hormone and learn to survive even in the face of the testosterone-blocking drugs, giving the disease the ability to progress, Ryan said.

Zytiga is the first FDA-approved drug that can go inside the cancer cell and block it from making its own testosterone.

The trial involved 1,088 men who were being treated by 151 cancer centers in 12 countries. Each was given a low dose of the steroid prednisone, which works to combat the cancer

This is very good news. There is lots of positive news over the years. Often it seems to come to nothing years later. Promising drugs in the lab turn out to be far less promising in clinical trail. But very successful clinical trials are very good news. Even this kind of news though really should be confirmed by larger scale success, but this is a very good start.

Related: Global Cancer Deaths to Double by 2030Nanoparticles With Scorpion Venom Slow Cancer SpreadThe Only Known Animal That Doesn’t Get CancerUCSF Prostate Cancer Center

Good Chemistry: A Love Song for Ionic Bonds

Song and video by 10th grade student, Eli Cirino, for extra credit in his chemistry class.

An ionic bond is a type of chemical bond formed through an electrostatic attraction between two oppositely charged ions. Ionic bonds are formed between a cation, which is usually a metal, and an anion, which is usually a nonmetal.

An ionic bond is considered a bond where the ionic character is greater than the covalent character (ionic bonds cannot exist on their own, they must have a covalent bond present also).

Related: Protein Synthesis: 1971 VideoCooking with Chemistry: Hard CandyThe Chemistry of Hair Coloring

Scientific Inquiry Process Finds More Evidence Supporting Einstein’s Theory

As scientists have been able to see farther and deeper into the universe, the laws that govern its expansion have been revealed to be under the influence of an unexplained force.

In a paper on the arXiv, Astrophysical Tests of Modified Gravity: Constraints from Distance Indicators in the Nearby Universe, are a vindication of Einstein’s theory of gravity. Having survived several decades of tests in the solar system, it has passed this new test in galaxies beyond our own as well.

In 1998, astrophysicists made an observation that turned gravity on its ear: the universe’s rate of expansion is speeding up. If gravity acts the same everywhere, stars and galaxies propelled outward by the Big Bang should continuously slow down, like objects thrown from an explosion do here on Earth.

This observation used distant supernovae to show that the expansion of the universe was speeding up rather than slowing down. This indicated that something was missing from physicists’ understanding of how the universe responds to gravity, which is described by Einstein’s theory of general relativity. Two branches of theories have sprung up, each trying to fill its gaps in a different way.

One branch — dark energy — suggests that the vacuum of space has an energy associated with it and that energy causes the observed acceleration. The other falls under the umbrella of “scalar-tensor” gravity theories, which effectively posits a fifth force (beyond gravity, electromagnetism and the strong and weak nuclear forces) that alters gravity on cosmologically large scales.

“These two possibilities are both radical in their own way,” University of Pennsylvania astrophysicist Bhuvnesh Jain said. “One is saying that general relativity is correct, but we have this strange new form of energy. The other is saying we don’t have a new form of energy, but gravity is not described by general relativity everywhere.”

Jain’s research is focused on the latter possibility; he is attempting to characterize the properties of this fifth force that disrupts the predictions general relativity makes outside our own galaxy, on cosmic length scales. Jain’s recent breakthrough came about when he and his colleagues realized they could use the troves of data on a special property of a common type of star as an exquisite test of gravity.

Continue reading

Modeling Weight Loss Over the Long Term

Researchers at the National Institutes of Health have created a mathematical model of what happens when people of varying weights, diets and exercise habits try to change their weight. The findings challenge the commonly held belief that eating 3,500 fewer calories, or burning them off exercising, will result in a pound of weight loss.

Instead, the researchers’ computer simulations indicate that this assumption overestimates weight loss because it fails to account for how metabolism changes. The computer simulations show how these metabolic changes can significantly differ among people.

However, the computer simulation of metabolism is meant as a research tool and not as a weight-loss guide for the public. The computer program can run simulations for changes in calories or exercise that would never be recommended for healthy weight loss. The researchers hope to use the knowledge gained from developing the model and from clinical trials in people to refine the tool for everyone.

“This research helps us understand why one person may lose weight faster or slower than another, even when they eat the same diet and do the same exercise,” said Kevin Hall, Ph.D., an obesity researcher and physicist at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases. “Our computer simulations can then be used to help design personalized weight management programs to address individual needs and goals.”

The online simulation tool based on the model enables researchers to accurately predict how body weight will change and how long it will likely take to reach weight goals based on a starting weight and estimated physical activity. The tool simulates how factors such as diet and exercise can alter metabolism over time and thereby lead to changes of weight and body fat.

The team found that people’s bodies adapt slowly to changes in dietary intake. They also found heavier people can expect greater weight change with the same change in diet, though reaching a stable body weight will take them longer than people with less fat.

The model also points to a potential simplified method to approximate weight loss in an average overweight person. An adult who has a body mass index (a measure of a person’s weight in relation to his or her height) between 25 and 29.9 is considered overweight. One example: For every pound you want to lose, permanently cut 10 calories from your current intake per day. At that rate, it will take about one year to achieve half of the total weight loss, and almost all of the weight loss will have occurred by three years. This calculation shows how long it takes to achieve a weight-loss goal for a single permanent change of diet or exercise.

Related: full press releaseHealthy Diet, Healthy Living, Healthy WeightStudy Shows Weight Loss From Calorie Reduction Not Low Fat or Low CarbObesity Epidemic Largely Explained$500 Million to Reduce Childhood Obesity in USA

Continue reading

Video of Young Richard Feynman Talking About Scientific Thinking

The enjoyable video above shows a young Richard Feynman discussing how scientific thinking can advance our understanding of the world.

Related: Feynman “is a second Dirac, only this time human”Science and the Excitement, the Mystery and the Awe of a FlowerClassic Feynman: All the Adventures of a Curious Character

Majority of Clinical Trials Don’t Provide Meaningful Evidence

The largest comprehensive analysis of ClinicalTrials.gov finds that clinical trials are falling short of producing high-quality evidence needed to guide medical decision-making.

The analysis, published today in the Journal of the American Medical Association, found the majority of clinical trials is small, and there are significant differences among methodical approaches, including randomizing, blinding and the use of data monitoring committees.

This is a critical issue as medical studies continue to leave quite a bit to be desired. Even more importantly the failure to systemically study and share evidence of effectiveness once treatments are authorized leaves a great deal to be desired. On top of leaving quite a bit to be desired, the consequences are serious. If we make mistakes for example in how we date fossils it matters but it is unlikely to cause people their lives or health. Failure to adequately manage and analyze health care experiments may very well cost people their health or lives.

“Our analysis raises questions about the best methods for generating evidence, as well as the capacity of the clinical trials enterprise to supply sufficient amounts of high quality evidence to ensure confidence in guideline recommendations,” said Robert Califf, MD, first author of the paper, vice chancellor for clinical research at Duke University Medical Center, and director of the Duke Translational Medicine Institute.

The analysis was conducted by the Clinical Trials Transformation Initiative (CTTI), a public-private partnership founded by the Food and Drug Administration (FDA) and Duke. It extends the usability of the data in ClinicalTrials.gov for research by placing the data through September 27, 2010 into a database structured to facilitate aggregate analysis.

Related: Statistical Errors in Medical StudiesHow to Deal with False Research FindingsMedical Study Integrity (or Lack Thereof)

Continue reading

New Blog with Simple Demonstrations and Scientific Explanations

Try this at home is a new blog by Dr Mark Lorch, a chemistry lecturer at the University of Hull, with instructions for the citizen scientist. This example shows how to move a can with a ballon without touching the can.

The posts include instructions on how to do these simple demonstrations and a nice explanation on the scientific reason for what is going on:

Rubbing the balloon on your hair charges it up with static electricity which makes the balloon negatively charged. When you put the balloon near the can it pushes electrons (which are also negatively charged) to the other side of the can. This makes the side which is nearest the balloon positively charged. Positive charges are attracted to negative charges so the can moves towards the balloon.

It is quite a nice site (especially if you have kids interested in science or are a kid interested in science – no matter how old you are), add it to your RSS reader. Here are some more science blogs you may enjoy.

Related: The DIY Movement Revives Learning by DoingHome Engineering: Building a HovercraftTeaching Through Tinkering

Fossil or Mystery Monster Found In Kentucky Seems to Defy All Known Groups of Organisms

Around 450 million years ago, shallow seas covered the Cincinnati region and harbored one very large and now very mysterious organism. Despite its size, no one has ever found a fossil of this “monster” until its discovery by an amateur paleontologist last year.

UC Paleontologist David Meyer, left and Carlton Brett, right, flank Ron Fine, who discovered the large fossil spread out on the table.

The fossilized specimen, a roughly elliptical shape with multiple lobes, totaling almost seven feet in length, will be unveiled at the North-Central Section 46th Annual Meeting of the Geological Society of America, April 24, in Dayton, Ohio.

Fine is a member of the Dry Dredgers, an association of amateur paleontologists based at the University of Cincinnati. The club, celebrating its 70th anniversary this month, has a long history of collaborating with academic paleontologists.

“I knew right away that I had found an unusual fossil,” Fine said. “Imagine a saguaro cactus with flattened branches and horizontal stripes in place of the usual vertical stripes. That’s the best description I can give.”

The layer of rock in which he found the specimen near Covington, Kentucky, is known to produce a lot of nodules or concretions in a soft, clay-rich rock known as shale. “While those nodules can take on some fascinating, sculpted forms, I could tell instantly that this was not one of them,” Fine said. “There was an ‘organic’ form to these shapes. They were streamlined.”

Continue reading

Harvard Steps Up Defense Against Abusive Journal Publishers

For a decade journals have been trying to continue a business model that was defensible in a new world where it is not. They have becoming increasing abusive with even more outrageous fees than they were already charging. As I said years ago it has become obvious they are enemies of science and should be treated as such. The time to find mutual beneficial solution past years ago.

Harvard University says it can’t afford journal publishers’ prices

Exasperated by rising subscription costs charged by academic publishers, Harvard University has encouraged its faculty members to make their research freely available through open access journals and to resign from publications that keep articles behind paywalls.

A memo from Harvard Library to the university’s 2,100 teaching and research staff called for action after warning it could no longer afford the price hikes imposed by many large journal publishers, which bill the library around $3.5m a year.

he memo from Harvard’s faculty advisory council said major publishers had created an “untenable situation” at the university by making scholarly interaction “fiscally unsustainable” and “academically restrictive”, while drawing profits of 35% or more. Prices for online access to articles from two major publishers have increased 145% over the past six years, with some journals costing as much as $40,000, the memo said.

More than 10,000 academics have already joined a boycott of Elsevier, the huge Dutch publisher, in protest at its journal pricing and access policies. Many university libraries pay more than half of their journal budgets to the publishers Elsevier, Springer and Wiley.

Research Libraries UK negotiated new contracts with Elsevier and Wiley last year after the group threatened to cancel large subscriptions to the publishers. The new deal, organised on behalf of 30 member libraries, is expected to save UK institutions more than £20m.

These journals have continuously engaged in bad practices. Scientists should publish work in ways that enrich the scientific community not ways that starve the scientific commons and enrich a few publishers that are doing everything they can to hold back information sharing.

In 2008 Harvard’s liberal arts faculty voted to make their research open source.

Related: Fields Medalist Tim Gowers Takes Action To Stop Cooperating with Anti-Open Science CartelScience Commons: Making Scientific Research Re-usefulMIT Faculty Open Access to Their Scholarly ArticlesMerck and Elsevier Publish Phony Peer-Review JournalOpen Access Journal Wars

How do Plants Grow Into the Sunlight?

Plants are extremely competitive in gaining access to sunlight. A plant’s primary weapon in this fight is the ability to grow towards the light, getting just the amount it needs and shadowing its competition. Now, scientists have determined precisely how leaves tell stems to grow when a plant is caught in a shady place.

photo of a forest

Hole in the Wall trail, Olympic National Park, Washington, USA by John Hunter

The researchers discovered that a protein known as phytochrome interacting factor 7 (PIF7) serves as the key messenger between a plant’s cellular light sensors and the production of auxins, hormones that stimulate stem growth.

“We knew how leaves sensed light and that auxins drove growth, but we didn’t understand the pathway that connected these two fundamental systems,” says Joanne Chory, professor and director of the Salk’s Plant Biology Laboratory and a Howard Hughes Medical Institute investigator (HHMI provides huge amounts of funding for scientific research). “Now that we know PIF7 is the relay, we have a new tool to develop crops that optimize field space and thus produce more food or feedstock for biofuels and biorenewable chemicals.”

Plants gather intelligence about their light situation—including whether they are surrounded by other light-thieving plants—through photosensitive molecules in their leaves. These sensors determine whether a plant is in full sunlight or in the shade of other plants, based on the wavelength of red light striking the leaves. This is pretty cool; I love to learn about the brilliant strategies that have evolved.

If a sun-loving plant, such as thale cress (Arabidopsis thaliana), the species Chory studies, finds itself in a shady place, the sensors will tell cells in the stem to elongate, causing the plant to grow upwards towards sunlight.

When a plant remains in the shade for a prolonged period, however, it may flower early and produce fewer seeds in a last ditch effort to help its offspring spread to sunnier real estate. In agriculture, this response, known as shade avoidance syndrome, results in loss of crop yield due to closely planted rows of plants that block each other’s light.

Continue reading